Skip Navigation

Dream Pharma and Kunwha Pharmaceuticals to become Alvogen Korea

01 June 2015
  • Name change follows the recent merger of two of South Korea’s pharmaceutical companies
  • Alvogen Korea will be among the leading players in the local market with strong international ties

Alvogen’s subsidiaries in Korea, Kunwha Pharmaceuticals and Dream Pharma have announced that they will trade as Alvogen Korea from June 2015. The decision follows the recent merger of Kunwha with Dream Pharma, a market leader in the Korean anti-obesity market. The name change will further strengthen international ties with Alvogen and support growth plans in the region.

In addition to the name change, Alvogen Korea will adopt a new corporate identity which is both modern and unique in the pharmaceutical field. It has been designed to capture a unified, progressive, collaborative and innovative organization and the yellow corporate color conveys vibrancy and energy. ALVO means target or goal, it also means outstanding. The latter part, GEN, links us to the future generation.

“There were a number of compelling reasons to rebrand the combined company to Alvogen,

Renaat Jenssen

Executive Vice President of Alvogen APAC.